Skip to main content

drug development Articles

New Alzheimer’s drug too good to be true?

New Alzheimer’s drug too good to be true?

Lecanemab is the first drug to change the course of Alzheimer’s disease, but two deaths during its clinical trial have raised questions about the drug’s safety.
Rediscovering folk remedies before it’s too late

Rediscovering folk remedies before it’s too late

New drugs could be hiding in charming, traditional remedies
Chinese New Year special: science and the pig

Chinese New Year special: science and the pig

Chinese New Year is right around the corner, and contributor Ella Gerry takes the opportunity to explore the significance of the pig in science research.
£6.8 million awarded to Manchester health consortium

£6.8 million awarded to Manchester health consortium

The new funding could allow upscaling of personalised medicine and development of new cancer therapies

Controversy: Animal testing

This week, Senior Science & Technology Reporter, Serena Holloway, tackles the ongoing debate on animal testing in pharmaceutical development